Follow-up Study of Safety and Efficacy in Subjects Who Completed NEUROSTEM Phase-I/IIa Clinical Trial
Latest Information Update: 16 Mar 2023
At a glance
- Drugs Mesenchymal stem cell therapy Medipost (Primary)
- Indications Alzheimer's disease
- Focus Therapeutic Use
- Sponsors Medipost
- 13 Mar 2023 Status changed from recruiting to completed.
- 06 Jun 2017 New trial record